An Act relative to the substitution of interchangeable biosimilars
By Mr. Cusack of Braintree, a petition (subject to Joint Rule 12) of Mark J. Cusack, Steven M. Walsh and Jennifer E. Benson relative to the substitution of interchangeable biosimilars. Health Care Financing.
Bill History
| Date | Branch | Action |
|---|---|---|
| 9/12/2013 | House | Referred to the committee on House Rules |
| 9/23/2013 | House | Reported, referred to the committee on Joint Rules, reported, rules suspended and referred to the committee on Health Care Financing |
| 9/26/2013 | Senate | Senate concurred |
| 10/17/2013 | Joint | Hearing scheduled for 10/22/2013 from 01:00 PM-04:00 PM in A-1 |
| 11/4/2013 | House | Accompanied a new draft, see H3734 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.